Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99

Fig. 4

Spaghetti plots with summary of plasma HER2ECD levels of the two arms’ cohort behavior: red lines Arm A and turquoise lines Arm B. Observation time points: Base: Baseline mean values before-after first injection; d1c2: day 1 s cycle (after 3 weeks); ass1: first assessment at 8–9 weeks; PD1: first progression; PD2: second progression

Back to article page